VOLUME 14, ISSUE 13 / JULY 2022
White Paper
Biomarker context-of-use: how organizational design can impact the implementation of the appropriate biomarker assay strategy
- Kyra J Cowan,
- Michaela Golob,
- Joanne Goodman,
- Anna Laurén,
- Lene Andersen,
- Philip De Decker,
- Lien Dejager,
- Marianne Scheel Fjording,
- Peter Groenen,
- Renaud Jasnowski,
- Nicole Justies,
- Matti Kimberg,
- Ulrich Kunz,
- James Lawrence,
- Mario Richter,
- Laetitia Sordé,
- Radboud van Trigt,
- Laurent Vermet,
- Alessandra Vitaliti,
- Michael Wright &
- Philip Timmerman
- Pages:911–917
- Published Online:29 July 2022
Technology Digest
JUNE 2022
Understanding drug–protein binding and ADME studies for DMPK
- Vivian Xie
- Pages:919–921
- Published Online:15 June 2022
Methodology
SEPTEMBER 2022
Comparison of assay formats used for the detection of pre-existing anti-drug antibodies against monoclonal antibodies
- Alexander Pöhler,
- Thomas Emrich
, - Gregor Jordan,
- Martin Schäfer,
- Kay-Gunnar Stubenrauch,
- Roland F Staack,
- Carolin Zach,
- Julian Meir &
- Janine Faigle
- Pages:923–933
- Published Online:6 September 2022
Research Article
JULY 2022
Validation of a method to analyze size distribution of crovalimab-complement C5–eculizumab complexes in human serum
- Masanobu Nishidate ,
- Norihito Shibahara,
- Akira Hayasaka,
- Roland F Staack,
- Takashi Miyayama,
- Kimio Terao &
- Gregor Jordan
- Pages:935–947
- Published Online:29 July 2022
Review
AUGUST 2022
Surrogate peptide selection and internal standardization for accurate quantification of endogenous proteins
- Mrunal Palshikar ,
- Tarang Jadav ,
- Niraj Rajput ,
- Amit Kumar Sahu &
- Pinaki Sengupta
- Pages:949–961
- Published Online:26 August 2022